APA

Pellegrin M., Szostak J., Bouzourène K., Aubert J., Berthelot A., Nussberger J., Laurant P. & Mazzolai L. (2017). Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. : Journal of cardiovascular pharmacology and therapeutics.

Chicago

Pellegrin Maxime, Szostak Justyna, Bouzourène Karima, Aubert Jean-François, Berthelot Alain, Nussberger Jürg, Laurant Pascal and Mazzolai Lucia. 2017. Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. : Journal of cardiovascular pharmacology and therapeutics.

Harvard

Pellegrin M., Szostak J., Bouzourène K., Aubert J., Berthelot A., Nussberger J., Laurant P. and Mazzolai L. (2017). Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. : Journal of cardiovascular pharmacology and therapeutics.

MLA

Pellegrin Maxime, Szostak Justyna, Bouzourène Karima, Aubert Jean-François, Berthelot Alain, Nussberger Jürg, Laurant Pascal and Mazzolai Lucia. Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions. : Journal of cardiovascular pharmacology and therapeutics. 2017.